title: Half of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers.
authors.affiliation: New York.
authors.forename: Jeanne
authors.initials: J
authors.lastname: Lenzer
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D016265:Conflict of Interest; D004345:Drug Industry; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D010820:Physicians / Q000941:ethics*; D017410:Practice Guidelines as Topic
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors